AI and early digital twin models can help forecast trial performance, refine site feasibility, and anticipate operational needs before enrollment begins.
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Why Are Study Builds The Same As Decades Ago?
It seems that we as an industry have held onto a technology mindset that is no longer serving our needs. It’s time to move to a better way. Read our blog on the disconnect between clinical trial technology and legacy habits.
-
What Is Electronic Data Capture And How Does It Simplify Data Management?
As EDC systems continue to evolve, they streamline workflows, enhance data security, and improve patient outcomes.
-
The Agentic AI Connectors That Matter In Clinical Development
An inside look at the architecture behind agentic AI in clinical research, including how modular agents, connectors, and MCP frameworks enable scalable, interoperable automation across complex trial ecosystems.
-
CRO Takes Trial Build Times From Weeks To Days
Recognizing the inefficiencies in traditional build processes, a top global CRO partnered with Medable to transform its approach to clinical trial launch.
-
Enhancing Participant Payments: A New Approach
Managing participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.
-
Re-Consent In Clinical Trials: Streamlining With eConsent
Delve into a variety of triggers for initiating re-consent, perspectives of regulators and IRBs regarding the re-consent process, and the role of digital processes in preventing issues related to re-consent.
-
A Data-Driven Approach To Clinical Trial Site Selection
By incorporating data-driven site selection and verification, sponsors can optimize resource allocation, enhance protocol compliance, and improve overall trial integrity.
-
Medable Platform Delivers >90% eCOA Adherence And Scalability
Discover how eCOA use drove >90% adherence across an extensive weight management master protocol clinical trial with multiple sub-studies across 70+ research sites.
-
Paperless Online Remote Source Document Verification
Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.
-
Immuno-Inflammation Clinical Trials: Challenges And Solutions
Learn why having a strong and robust eCOA solution, along with an understanding of the specific challenges of this therapeutic area, is critical to the success of immuno-inflammation clinical trials.
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
RECENT NEWSLETTERS
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps